Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2)
术前帕博利珠单抗(抗PD-1抗体)联合放化疗治疗食管鳞状细胞癌:一项1/2期试验(PALACE-2)
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02477-4
Li, Chengqiang; Han, Yichao; Zhao, Shengguang; Kang, Xiaozheng; Zheng, Yuyan; Cao, Yuqin; Yan, Yan; Shi, Liqiang; Wang, Xipeng; Lu, Tong; Zou, Guowen; Li, Huan; Che, Jiaming; Xiang, Jie; Zhu, Lianggang; Hang, Junbiao; Zhang, Yajie; Jin, Runsen; Han, Dingpei; Chen, Xueyu; Jing, Hui; Guo, Wei; Cheng, Zenghui; Zhao, Liqin; Chen, Xiaoyan; Yu, Bentong; Li, Jian; Li, Bin; Li, Yin; Li, Hecheng